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family and is involved in multiple cellular responses, including chemotaxis. Despite its biological
signiﬁcance, the mechanisms of BLT2 regulation, especially by protein kinases, are poorly character-
ised. In this study, we found that Akt phosphorylates BLT2 at its C-terminal Thr355 residue and that
this event is critical for BLT2-mediated chemotactic responses. In addition, we found that Rac1
stimulation and subsequent reactive oxygen species (ROS) production lie downstream of BLT2 phos-
phorylation, thus mediating chemotaxis.
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Leukotriene B4 (LTB4), a lipid metabolite generated from arachi-
donic acid (AA) by the action of the 5-lipoxygenase (5-LO) path-
way, is one of the most potent chemoattractants for the
recruitment of leukocytes. LTB4 mediates its biological effects via
two G protein-coupled receptors (GPCRs), LTB4 receptor 1 (BLT1)
and BLT2 [1–3]. Most studies of LTB4 receptors have focused on
the high-afﬁnity receptor BLT1, which is expressed mainly in
inﬂammatory cells such as leukocytes and plays a role in inﬂam-
matory processes [2,4]. In contrast, the physiological function of
BLT2, a low-afﬁnity receptor for LTB4 that is expressed in a wide
variety of tissues, is not fully understood [3,5]. The LTB4-BLT2
signalling cascade is associated with the generation of reactive
oxygen species (ROS) and mediates cell chemotaxis [1,6,7].
Akt has been suggested to be involved in GPCR-mediated che-
motactic signal transduction [8–9]. Upon chemotactic receptor
activation, Gbc subunits released from Ga initiate signalling events
leading to chemotaxis by activating phosphoinositide-3-kinase
(PI3K)-c and subsequently Akt [10]. Akt recognises and phosphor-
ylates the consensus amino acid sequence RxRxxS/T, which haschemical Societies. Published by E
tein-coupled receptor; ROS,
Sciences and Biotechnology,
l 136-701, Korea. Fax: +82 2been identiﬁed within several substrates [11–12]. Although Akt
plays a role in GPCR-mediated chemotactic signal transduction,
the molecular mechanisms by which Akt regulates chemotaxis re-
main largely unknown, especially in BLT2-mediated chemotaxis.
In this study, we describe a signalling mechanism that involves
the phosphorylation of BLT2 by the protein kinase Akt in LTB4-in-
duced chemotactic migration. Our ﬁndings indicate that Thr355 in
the BLT2 cytoplasmic tail (C-tail) region is phosphorylated by Akt
and that this event triggers LTB4-induced chemotaxis via a Rac1/
ROS-linked cascade. These ﬁndings point to one potential route
by which BLT2 is regulated by protein kinase(s), and they will con-
tribute to a better understanding of how GPCR signalling promotes
chemotaxis.
2. Materials and methods
All experiments were performed using CHO cells. A detailed
description of the methods that were used in this study is provided
in the Supplementary materials and methods.
3. Results
3.1. Akt phosphorylation of the BLT2 C-tail region
To study BLT2 regulation by protein kinases, we ﬁrst searched
for potential phosphorylation sites in the BLT2 C-tail region using
the NetPhos 2.0 Server prediction program (http://www.cbs.dtu.
dk/services/NetPhos). The prediction program identiﬁed six poten-lsevier B.V. All rights reserved.
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phorylation sites (position 342, 351, 355, and 361) showed
scores > 0.5 (Supplementary Table 1) [13]. Among these, we no-
ticed that the sequence RSREGT355 in the BLT2 C-tail region
matched the consensus site for Akt phosphorylation (RxRxxT/S)
[14]. Furthermore, this consensus site for Akt phosphorylation in
the BLT2 C-tail region is conserved in the human, mouse, and rat
sequences (data not shown). Therefore, we next assessed whether
Akt is the kinase responsible for BLT2 Thr355 phosphorylation
following LTB4 treatment. First, we observed that endogenous
Akt was indeed activated by LTB4 treatment in a dose-dependent
manner (up to 300 nM LTB4), especially in CHO cells stably
expressing human BLT2 (Fig. 1A). Moreover, Akt activation was
blocked by pretreatment with either LY294002 (an inhibitor of
PI3K) or pertussis toxin (PTX; an inhibitor of the Gai family)
(Fig. 1B). Next, we examined whether Akt is capable of interacting
directly with the C-tail domain of BLT2. For this experiment, we
prepared glutathione S-transferase (GST)-tagged wild-type C-tail
(GST-BLT2 C-tail WT) and C-tail mutant (GST-BLT2 C-tail T355A)
BLT2 constructs. As shown in Fig. 1C, Akt interacted equally well
with GST-BLT2 C-tail WT and GST-BLT2 C-tail T355A. Next, we
examined whether the active form of Akt (Myr-Akt) is capable of
phosphorylating the C-tail region of BLT2 in vitro. For this test,
either GST-BLT2 C-tail WT or GST-BLT2 C-tail T355A was incubatedFig. 1. Akt is the kinase responsible for phosphorylating BLT2 in the C-tail region.
concentrations of LTB4 for 5 min. The cell lysates were analysed for Akt phosphorylation b
preincubated for 30 min with 20 lM LY294002 or for 10 h with 100 ng/ml PTX prior to ex
A pull-down assay was performed using equal amounts of GST control protein, GST-BLT
bound proteins were incubated with Myc-tagged WT-Akt-transfected CHO cell extracts a
(D) CHO cells were transfected with Myc-tagged Akt and immunoprecipitated with
determined using an in vitro kinase assay as described in the Supplementary materials a
basic protein (MBP). (E) CHO cells were co-transfected with HA-tagged wild-type BLT2 a
were exposed to 300 nM LTB4 for 5 min and immunoprecipitated with HA-speciﬁc ant
(PAGE) and autoradiographed. The potentially phosphorylated BLT2 band is indicate
representative of three independent experiments with similar results.with active Akt kinase (Myr-Akt) in vitro. As shown in Fig. 1D,
whereas the GST-BLT2 C-tail WT domain was highly phosphory-
lated by Myr-Akt, the GST-BLT2 C-tail T355A mutant was only
weakly phosphorylated by Myr-Akt in vitro. Furthermore, we
examined whether Akt could indeed phosphorylate BLT2 in cells
using [32P]orthophosphate labelling. Upon BLT2 stimulation with
LTB4, BLT2 was highly phosphorylated after transfection with
wild-type Akt (WT-Akt), but this effect was not observed after
transfection with a dominant-negative mutant of Akt (DN-Akt)
(Fig. 1E). Taken together, these results suggest that Akt is activated
by LTB4 treatment and phosphorylates the BLT2 C-tail region, at
least at the Thr355 residue.
3.2. Akt phosphorylation of the BLT2 C-tail (Thr355) region is necessary
for LTB4-induced chemotaxis
Akt plays critical roles in various cellular responses, including
chemotactic migration [15–17]. Also, BLT2 mediates chemotaxis
after stimulation with its ligand LTB4 [3,16]. Based on these ﬁnd-
ings, we examined whether Akt-mediated phosphorylation of
BLT2 Thr355 plays any role in BLT2-mediated chemotaxis. When
CHO cells stably expressing BLT2 were stimulated with increasing
concentrations of LTB4, a bell-shaped dose-dependent chemotactic
activity curve resulted, whereas CHO cells stably transfected with(A) Serum-starved CHO and stable CHO-BLT2 cells were exposed to increasing
y immunoblotting. (B) CHO and stable CHO-BLT2 cells were serum-starved and then
posure to 300 nM LTB4 for 5 min, after which Akt phosphorylation was assessed. (C)
2 C-tail WT, or GST-BLT2 C-tail T355A bound to glutathione-Sepharose beads. The
nd immunoblotted with anti-Myc antibody. a-Tubulin was used as a loading control.
anti-Myc antibody. Akt-mediated phosphorylation of the BLT2 C-tail region was
nd methods. The activity of the kinase was measured by phosphorylation of myelin
nd either WT-Akt or DN-Akt and then labelled with [32P]orthophosphate. The cells
ibody. The cell lysates were separated by SDS–polyacrylamide gel electrophoresis
d by an arrow and asterisk; a-tubulin was used as a loading control. Data are
Fig. 2. Akt-mediated phosphorylation (Thr355) of the BLT2 C-tail is necessary for chemotaxis. (A) LTB4-induced chemotactic motility was determined in CHO (s) and stable
CHO-BLT2 (d) cells as described in Supplementary materials and methods. (B) CHO and stable CHO-BLT2 cells were exposed to 300 nM LTB4 for 3 h, after which migrating
cells were ﬁxed and stained with haematoxylin/eosin. Migration activity was expressed as percent of control. (C) LTB4-induced chemotactic motility was determined in the
presence of 20 lM LY294002 or 100 ng/ml PTX. The inhibitor was added 30 min (for LY294002) or 10 h (for PTX) prior to the addition of LTB4. (D) CHO and stable CHO-BLT2
cells were transiently transfected with DN-Akt, after which transfectants were assayed for chemotaxis as described above. (E) CHO cells expressing wild-type or mutant BLT2
were exposed to 300 nM LTB4 for 3 h and then assayed for chemotaxis as described above. pcDNA3.1-expressing CHO cells were used as a control in all experiments. Data are
presented as means ± S.D. of three independent experiments.
J.-D. Wei et al. / FEBS Letters 585 (2011) 3501–3506 3503control vector showed no chemotactic motility after LTB4 treat-
ment (Fig. 2A). For example, 300 nM LTB4 elicited signiﬁcantly
increased (3-fold over the control) chemotactic migration
(Fig. 2B). This effect was, however, markedly blocked by pretreat-
ment with LY294002 (Fig. 2C) or transfection with the DN-Akt
mutant (Fig. 2D), suggesting that Akt mediates LTB4/BLT2-depen-
dent chemotaxis. Likewise, LTB4/BLT2-mediated chemotaxis was
inhibited by PTX treatment (Fig. 2C). We next examined the ability
of LTB4 to elicit chemotaxis from the BLT2 T355A mutant, which is
defective for phosphorylation by Akt. As shown in Fig. 2E, LTB4-
elicited chemotaxis was not observed in cells transfected with
the BLT2 T355A mutant, whereas cells transfected with wild-type
BLT2 showed signiﬁcant chemotactic motility in response to
LTB4. In addition, these effects were similarly observed in response
to a speciﬁc BLT2-stimulating agonist CAY10583 (also known as
Compound A) or a BLT2 natural ligand 12 (S)-hydroxyheptadeca-
5Z, 8E, 10E-trienoic acid (12-HHT) [18] (Supplementary Fig. 1).
Together, these results suggest that Akt is likely to mediate chemo-
tactic motility through phosphorylation of BLT2 at Thr355.3.3. Akt phosphorylation of the BLT2 C-tail (Thr355) is followed by Rac1
activation and subsequent ROS generation, thereby mediating
chemotaxis
LTB4-induced ROS generation is involved in chemotaxis [1], and
ROS generation occurs through a BLT2-dependent pathway [7]. In
addition, we previously reported that Rac1, a member of the Rho
family of GTPases, plays a crucial mediatory role in ROS generation
in cells [1,19–20]. We therefore examined whether Akt phosphor-
ylation of the BLT2 C-tail at Thr355 is followed by Rac1 activation
and ROS generation, thus mediating chemotaxis. To assess whether
Rac1 is involved in BLT2-mediated chemotactic signalling, we ﬁrst
analysed the effect of RacN17, a dominant-negative Rac1 mutant, on
the chemotactic activity of CHO cells expressing BLT2. As shown in
Fig. 3A, the LTB4-induced chemotactic migration of cells expressing
BLT2 was signiﬁcantly diminished by RacN17. This result led us to
test the extent to which LTB4 exposure stimulates cellular Rac1
activity. Rac1 activity was signiﬁcantly increased by the addition
of LTB4 in cells expressing wild-type BLT2 (2.14-fold over the con-
Fig. 3. BLT2-mediated Rac1 activation depends on Akt phosphorylation of BLT2 at Thr355. (A) LTB4-induced chemotactic motility was analysed in CHO or CHO-BLT2 cells
transiently transfected with empty vector or vector expressing RacN17. Data are presented as means ± S.D. of three independent experiments. (B) CHO and stable CHO-BLT2
cells were serum-starved for 24 h and then preincubated for 30 min with 20 lM LY294002 or for 10 h with 100 ng/ml PTX prior to exposure to 300 nM LTB4 for 5 min. Cell
lysates were incubated with GST-PAK-PBD coupled to glutathione-Sepharose beads and immunoblotted with anti-Rac1 antibody. Data are representative of three
independent experiments with similar results. (C) CHO and stable CHO-BLT2 cells were transiently transfected with DN-Akt, after which transfectants were serum-starved
and assayed for Rac1 activity as described above. (D) CHO cells expressing wild-type or mutant forms of BLT2 were serum-starved and assayed for Rac1 activity. Rac1
activation was measured and expressed as fold of control. Data are presented as means ± S.D. of three independent experiments. pcDNA3.1-expressing CHO cells were used as
a control (A–D).
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or PTX (Fig. 3B). Furthermore, LTB4-induced Rac1 activation was
markedly inhibited by co-transfection with DN-Akt, suggesting
that Akt lies upstream of Rac1 activation in the LTB4-BLT2 signal-
ling pathway (Fig. 3C). We further examined whether BLT2
T355A would show any Rac1 activation in response to LTB4. As
shown in Fig. 3D, very little Rac1 activation was seen in cells trans-
fected with BLT2 T355A, whereas cells transfected with wild-type
BLT2 showed signiﬁcant Rac1 activation following LTB4 treatment.
Together, these results suggest that Akt phosphorylation of BLT2 at
Thr355 is necessary for Rac1 activation, which is critical for
chemotaxis.
Next, we examined whether Akt phosphorylation of BLT2 at
Thr355 mediates chemotaxis through ROS generation. As shown
in Fig. 4A, LTB4-induced chemotactic migration was signiﬁcantly
reduced by treatment with NAC, a free radical scavenger, in cells
stably expressing BLT2. Then, we assessed whether BLT2 stimula-
tion with LTB4 induces elevated intracellular ROS levels. After
LTB4 treatment, ROS levels in CHO cells expressing BLT2 were
increased about 2-fold (Fig. 4B). This effect was completely atten-
uated by pretreatment with LY294002 or PTX (Fig. 4C). Similarly,
we observed that LTB4/BLT2-evoked ROS generation was inhibited
by co-transfection with DN-Akt or RacN17 (Fig. 4D). We further
examined whether cells transfected with BLT2 T355A show anyROS generation in response to LTB4. As shown in Fig. 4E, LTB4-in-
duced ROS generation was absent in cells transfected with BLT2
T355A. Taken together, these results suggest that Akt phosphoryla-
tion of BLT2 at Thr355 leads to Rac1 activation and subsequent ROS
generation, which are critical for chemotaxis.
4. Discussion
In this study, we show that BLT2 C-tail phosphorylation at
Thr355 by Akt is critical for the LTB4-evoked BLT2-mediated chemo-
tactic response. Also, our data suggest that Rac1 activation and
subsequent ROS generation lie downstream of Akt phosphorylation
of BLT2 in the chemotactic LTB4 signalling pathway.
Leukotrienes (LTs) are potent inﬂammatory lipid mediators
generated from AA by the action of the 5-LO pathway [21]. Among
them, LTB4 acts via BLT1 and BLT2. These receptors belong to a
GPCR superfamily and share high similarity with other chemoat-
tractant receptors [22]. Unlike BLT1, the molecular mechanism
for BLT2 regulation remains unexplored. In most GPCRs, receptor
phosphorylation has long been recognised as an important regula-
tory mechanism for signalling [23]. To study BLT2 phosphorylation
by protein kinases, we ﬁrst searched for phosphorylation sites in
the BLT2 C-tail region and noticed that the sequence RSREGT355
in the BLT2 C-tail region matched the consensus site for Akt phos-
Fig. 4. BLT2-mediated ROS generation depends on Akt phosphorylation of BLT2 at Thr355. (A) LTB4-induced chemotactic motility was analysed after pretreatment with NAC
(2 mM) for 30 min in CHO and stable CHO-BLT2 cells. (B) CHO and stable CHO-BLT2 cells were stabilised in serum- and phenol red-free RPMI 1640 for at least 2 h prior to
exposure to 300 nM LTB4, after which DCF ﬂuorescence was monitored by ﬂow cytometry as described in Supplementary materials and methods. DCF ﬂuorescence was
expressed as fold of control. (C) CHO and CHO-BLT2 stable cells were exposed to 300 nM LTB4 in the presence of 20 lM LY294002, 2 mM NAC, or 100 ng/ml PTX. Each
inhibitor was added 30 min prior to the addition of LTB4, with the exception of PTX, which was added 10 h prior. (D) CHO and CHO-BLT2 cells were transiently transfected
with DN-Akt or RacN17, after which transfectants were serum-stabilised and assayed for ROS generation. (E) CHO cells expressing wild-type or mutant BLT2 were serum-
stabilised and assayed for ROS generation. Data are represented as means ± S.D. of three independent experiments.
J.-D. Wei et al. / FEBS Letters 585 (2011) 3501–3506 3505phorylation (RxRxxT/S). Thus, we examined whether Akt is capable
of phosphorylating BLT2 at Thr355. For these experiments, we pre-
pared a mutant with alanine substituted for Thr355 (Supplementary
Fig. 2). BLT2 expression was successfully detected by immunopre-
cipitation, and there were no differences in either cell membrane
expression or ligand-binding afﬁnity between wild-type BLT2
and the BLT2 T355A mutant (Supplementary Fig. 3). Therefore,
we excluded the possibility that unequal expression levels may
have been responsible for the observed phenotypes.
On the basis of our results, we have created a model that depicts
how Akt and BLT2 form an integrated pathway that leads to che-
motaxis (Supplementary Fig. 4). In the model, Rac1 activation lies
downstream of Akt-mediated BLT2 phosphorylation, which is con-
sistent with the ﬁndings that the small GTPase Rac1 plays a pivotal
role in actin reorganisation, cell polarisation, and chemotactic
migration [11,24]. Also in the model, Akt activation lies upstream
of BLT2 phosphorylation, and indeed we found that activation of
Akt itself by stimulation with LTB4 or CAY10583 (also known as
Compound A) were similar in wild-type BLT2 and the T355A mu-tant (Supplementary Fig. 1B and C). In support of our results, it
was previously reported that LTB4 stimulation transiently induces
Akt phosphorylation in murine bone marrow-derived mast cells
[9]. In addition, Shin et al. showed that LTB4-induced Akt activation
is BLT2-dependent in human monocyte-derived dendritic cells,
although they did not elucidate the exact mode of function of
Akt in the LTB4-BLT2 signalling axis [16]. Future studies aimed at
understanding how BLT2 stimulation by LTB4 leads to Akt activa-
tion are necessary. One possibility could be that ligand (e.g.,
LTB4)-induced dissociation of Gbc subunits plays a role in activat-
ing Akt, thus triggering BLT2 phosphorylation. In fact, accumulat-
ing evidence suggests that Gbc subunits released from Ga upon
stimulation of GPCRs lead to the activation of PI3K-c, and subse-
quently Akt [10]. The signaling mechanism by which BLT2 phos-
phorylation leads to Rac1 regulation has not been characterized,
but it was previously reported that Akt mediates phosphorylation
of sphingosine-1-phosphate receptor (EDG-1) to regulate Rac acti-
vation and subsequent chemotaxis [11]. Further, it was shown that
phosphorylated EDG-1 recruites Rac exchange factor Tiam1 and
3506 J.-D. Wei et al. / FEBS Letters 585 (2011) 3501–3506Rac to cell membrane [25]. Thus, we speculate that a similar
scenario may mediate Rac1 activation in response to BLT2 phos-
phorylation by Akt. Clearly, further experiments are necessary to
characterize the signaling mechanism by which BLT2 phosphoryla-
tion activates Rac1. In any event, to our knowledge, this is the ﬁrst
report deﬁning the role of a protein kinase in BLT2 regulation. This
novel mechanism should contribute to a better understanding of
how BLT2 signalling mediates chemotaxis.
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